Cooley advised Oyster Point Pharma on the deal, while Cravath represented Viatris. Oyster Point Pharma, a top ophthalmology-focused biopharmaceutical company, announced its definitive agreement to be acquired...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering while Cooley LLP represented sweetgreen. Sweetgreen, Inc. executed its initial public offering of Class A common stock at...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering while Cooley advised Allbirds. Allbirds, Inc., a global lifestyle brand that innovates with naturally derived materials to...
You must be a Standard 1 Year member to access this content.
